Show simple item record

dc.contributor.authorFernández Alba, Juan Jesús 
dc.contributor.authorCastillo Lara, María
dc.contributor.authorJiménez Heras, José Manuel
dc.contributor.authorMoreno Cortés, Rocío
dc.contributor.authorGonzález Macías, María del Carmen 
dc.contributor.authorVilar Sánchez, Angel 
dc.contributor.authorCarral San Laureano, Florentino
dc.contributor.authorMoreno Corral, Luis Javier 
dc.contributor.otherEnfermería y Fisioterapiaes_ES
dc.contributor.otherMaterno-Infantil y Radiologíaes_ES
dc.date.accessioned2022-11-24T08:25:22Z
dc.date.available2022-11-24T08:25:22Z
dc.date.issued2022-07
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/10498/27565
dc.description.abstractAlthough numerous articles have found an association between alterations in thyroid function and the risk of gestational diabetes mellitus (GDM), other studies have failed to demonstrate this association. This may be due to the different cut-off points used to define subclinical hypothyroidism. We aim to clarify the role of thyroid stimulating hormone (TSH) level in GDM within pregnant women with normal free thyroxine (fT4) levels. This retrospective cohort study was performed in 6775 pregnant women. The association between TSH and GDM was assessed by bivariate and multivariate logistic regression. Pregnant women with subclinical hypothyroidism are at significantly greater risk for GDM when compared with euthyroid pregnant women (OR = 1.85; 95% CI = 1.36-2.52). We have also observed that TSH levels increase the risk of GDM within euthyroid pregnant women, since the TSH levels between 2.5 and 4.71 showed a higher risk of GDM than those whose TSH levels are between 0.31 and 2.49 (OR = 1.54; 95% CI = 1.28-1.84). In addition, pregnant women with positive thyroid antibodies have almost 2.5 times the risk of developing GDM (OR = 2.47; 95% CI = 1.57-3.89). Our results support that in pregnant women with normal fT4 levels, higher first trimester TSH level implies a higher risk of GDM.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceJ. Clin. Med. 2022, 11, 3776.es_ES
dc.subjectgestational diabetes mellituses_ES
dc.subjectsubclinical hypothyroidismes_ES
dc.subjectsubclinical hyperthyroidismes_ES
dc.subjectthyroid stimulating hormonees_ES
dc.subjectthyrotropines_ES
dc.subjectthyroid antibodieses_ES
dc.titleHigh First Trimester Levels of TSH as an Independent Risk Factor for Gestational Diabetes Mellitus: A Retrospective Cohort Studyes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/jcm11133776


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional